Results 31 to 40 of about 201 (136)

Single Ascending Dose Safety and Pharmacokinetics of CDRI‐97/78: First‐in‐Human Study of a Novel Antimalarial Drug

open access: yesMalaria Research and Treatment, Volume 2014, Issue 1, 2014., 2014
Background. CDRI 97/78 has shown efficacy in animal models of falciparum malaria. The present study is the first in‐human phase I trial in healthy volunteers. Methods. The study was conducted in 50 healthy volunteers in a single, ascending dose, randomized, placebo‐controlled, double blind design.
N. Shafiq   +15 more
wiley   +1 more source

Pharmacokinetic Study and Bioavailability of a Novel Synthetic Trioxane Antimalarial Compound 97/63 in Rats

open access: yesMalaria Research and Treatment, Volume 2014, Issue 1, 2014., 2014
Single dose pharmacokinetics study of 97/63 (IND191710, 2004), a trioxane antimalarial developed by Central Drug Research Institute, Lucknow, India, was studied in rats following intravenous and oral administration. Serum samples were analysed by HPLC‐UV assay.
Hari Narayan Kushwaha   +4 more
wiley   +1 more source

Mechanistic Evaluation of the Stability of Arylvinyl-1,2,4-trioxanes under Acidic Conditions for Their Oral Administration as an Antimalarial Drug. [PDF]

open access: yesACS Omega, 2022
Kumari A   +8 more
europepmc   +1 more source

Lewis Acids and Heteropoly Acids in the Synthesis of Organic Peroxides. [PDF]

open access: yesPharmaceuticals (Basel), 2022
Yaremenko IA   +5 more
europepmc   +1 more source

1,2,4-Trioxolane and 1,2,4,5-Tetraoxane Endoperoxides against Old-World Leishmania Parasites: In Vitro Activity and Mode of Action. [PDF]

open access: yesPharmaceuticals (Basel), 2022
Mendes A   +6 more
europepmc   +1 more source

Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes. [PDF]

open access: yesACS Med Chem Lett, 2013
Maurya R   +10 more
europepmc   +1 more source

Effects of Albumin-Chlorogenic Acid Nanoparticles on Apoptosis and PI3K/Akt/mTOR Pathway Inhibitory Activity in MDA-MB-435s Cells. [PDF]

open access: yesNanomaterials (Basel), 2023
Alzahrani B   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy